Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia.

Autoantibodies cause platelet destruction in patients with immune thrombocytopenia (ITP); yet only 50% to 60% of patients have detectable platelet autoantibodies in peripheral blood. We hypothesized that in some ITP patients, platelet autoantibodies are sequestered in the bone marrow where pathological immune reactions target megakaryocytes or newly formed platelets. In this study, we modified the platelet glycoprotein-specific assay to test bone marrow aspiration samples for free platelet autoantibodies or antibodies bound to bone marrow cells in aspirate fluid from patients with ITP (n = 18), patients with nonimmune thrombocytopenia (n = 3), and healthy donors (n = 6). We found that 10 (56%) of 18 patients with ITP had autoantibodies in the bone marrow, including 5 (50%) of 10 with autoantibodies in bone marrow only, and 5 (50%) of 10 with autoantibodies in bone marrow and peripheral blood. In comparison, 6 (33%) of 18 ITP patients had autoantibodies in peripheral blood, most of whom (5 [83%] of 6) also had autoantibodies in bone marrow. Bone marrow autoantibodies were not detected in patients with nonimmune thrombocytopenia or healthy donors; however, peripheral blood autoantibodies were detectable in 1 (33%) of 3 patients with nonimmune thrombocytopenia. The sensitivity of platelet autoantibodies for the diagnosis of ITP increased from 60% (peripheral blood testing) to 72% (peripheral blood and bone marrow testing). Immune reactions limited to the bone marrow may be characteristic of certain subsets of ITP patients.

[1]  H. Al‐Samkari,et al.  A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia. , 2020, Blood advances.

[2]  J. Kelton,et al.  Increased cytotoxic potential of CD8+ T cells in immune thrombocytopenia , 2019, British journal of haematology.

[3]  S. Vesely,et al.  American Society of Hematology 2019 guidelines for immune thrombocytopenia. , 2019, Blood advances.

[4]  J. Kelton,et al.  The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta‐analysis of a diagnostic test , 2019, Journal of thrombosis and haemostasis : JTH.

[5]  A. Balduini,et al.  Autoantibodies in immune thrombocytopenia affect the physiological interaction between megakaryocytes and bone marrow extracellular matrix proteins , 2018, British journal of haematology.

[6]  J. Zwaginga,et al.  Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art , 2018, British journal of haematology.

[7]  J. Semple,et al.  Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP) , 2017, Journal of clinical medicine.

[8]  J. Kelton,et al.  Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia , 2016, British journal of haematology.

[9]  J. Kelton,et al.  Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia , 2015, European journal of haematology.

[10]  J. Kelton,et al.  The Mcmaster ITP Registry: Assessing the Prevalence, Clinical and Laboratory Features of Immune Thrombocytopenia , 2014 .

[11]  P. Lev,et al.  Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count , 2014, British journal of haematology.

[12]  J. Italiano,et al.  The incredible journey: From megakaryocyte development to platelet formation , 2013, The Journal of cell biology.

[13]  A. Greinacher,et al.  Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia , 2012, Journal of thrombosis and haemostasis : JTH.

[14]  J. Freedman,et al.  A murine model of severe immune thrombocytopenia is induced by antibody- and CD8+ T cell-mediated responses that are differentially sensitive to therapy. , 2010, Blood.

[15]  Sarita Joshi,et al.  Videos in clinical medicine. Bone marrow aspiration and biopsy. , 2009, The New England journal of medicine.

[16]  J. George,et al.  Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. , 2009, Blood.

[17]  B. Olsson,et al.  Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1. , 2008, Blood.

[18]  E. Vellenga,et al.  Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. , 2004, Blood.

[19]  B. Olsson,et al.  T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura , 2003, Nature Medicine.

[20]  Y. Ikeda,et al.  Spleen Is a Primary Site for Activation of Platelet-Reactive T and B Cells in Patients with Immune Thrombocytopenic Purpura1 , 2002, The Journal of Immunology.

[21]  J. Kelton,et al.  A prospective study of protein‐specific assays used to investigate idiopathic thrombocytopenic purpura , 1999, British journal of haematology.

[22]  Andreas Radbruch,et al.  Lifetime of plasma cells in the bone marrow , 1997, Nature.

[23]  C. E. Jones,et al.  Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. , 1994, Blood.

[24]  T. McDonald,et al.  Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP. , 1986, Blood.

[25]  D. Cines,et al.  Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. , 1985, Blood.

[26]  K. Clemetson,et al.  Autoantibodies against the platelet glycoproteins (GP) IIb/IIIa, Ia/IIa, and IV and partial deficiency in GPIV in a patient with a bleeding disorder and a defective platelet collagen interaction. , 1993, Blood.

[27]  J. Kelton,et al.  Investigation of the mechanisms of monoclonal antibody-induced platelet activation. , 1991, Blood.

[28]  M. G. Lötter,et al.  Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differ. , 1986, Blood.